Mono Pharmacare Balance Sheet Annual

BSE: - | NSE: MONOPHARMA | ISIN: INE0OIP01012 | Sector: Biotechnology & Drugs

8.90 +0.40 (4.71%)Updated : 09 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	122.29	110.05	81.11	81.10
Cash Equivalents	0.98	0.70	0.36	0.80
Other Liabilities Total	0.12	0.08	0.04	0.00
Long Term Debt	27.23	25.96	17.12	17.03
Common Stock Total	17.67	17.67	17.69	16.67
Other Equity Total	-0.38	-	-	-
Other Current Assets Total	0.97	0.88	1.20	0.87
Total Assets	122.29	110.05	81.11	81.10
Current Portof LT Debt/ Capital Leases	2.76	-	-	-
Total Equity	31.55	31.20	28.11	17.98
Long Term Investments	0.00	0.00	0.00	0.57
Retained Earnings( Accumulated Deficit)	14.26	13.53	10.42	1.32
Total Common Shares Outstanding	1.77	1.77	1.77	1.77
Tangible Book Valueper Share Common Eq	17.85	17.65	15.90	10.18
Total Liabilities	90.74	78.86	53.00	63.12
Total Debt	56.50	53.56	41.44	46.64
Cashand Short Term Investments	0.98	0.70	0.36	0.80
Total Receivables Net	76.91	52.03	36.31	38.88
Notes Payable/ Short Term Debt	26.51	27.60	24.32	29.61
Accounts Receivable- Trade Net	74.94	41.89	31.59	31.45
Property/ Plant/ Equipment Total- Net	0.89	1.00	0.90	1.13
Minority Interest	0.04	0.04	0.02	0.00
Total Current Liabilities	63.34	52.78	35.82	46.09
Total Inventory	42.43	55.39	42.29	38.78
Accounts Payable	29.22	18.80	9.69	13.87
Other Currentliabilities Total	4.85	6.38	1.82	2.61
Total Long Term Debt	27.23	25.96	17.12	17.03
Intangibles Net	0.01	0.01	0.01	-
Other Long Term Assets Total	0.08	0.04	0.01	0.05
Note Receivable- Long Term	0.01	0.01	0.03	0.01
period Length	0.00	0.00	0.00	0.00
Total Current Assets	121.30	108.99	80.16	79.32